Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 1,551–1,575 of 27,380 studies, newest first · page 63 of 1096.
March 2026 25
-
2026-03-13
Usability and feasibility of INFORMA platform for computerized cognitive stimulation in mild cognitive impairment and early dementia: an 8-week multicenter study
45/100 ✓ Peer-reviewed Cognitive tests and assessment Aging Clinical and Experimental Research
Key finding: Of 219 completing participants (mean age 73.5 years), the mean SUS score was 82.0 (95% CI: 80.3-83.8), with 84% exceeding the usability threshold (SUS score > 68). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Progress in Machine Learning-Assisted Biosensors for Alzheimer’s Disease
38/100 ✓ Peer-reviewed Digital health tools Biosensors
Key finding: This disease is associated with changes in the concentration of AD biomarkers, such as microRNAs, amyloid peptides, Tau protein, and neurofilament light chains.
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Late-life body mass index and Alzheimer disease conversion in mild cognitive impairment: Nonlinear risk and structural MRI correlates
40/100 ✓ Peer-reviewed Brain scans and imaging Archives of Gerontology and Geriatrics
Key finding: Over a median follow-up of 3.26 years, 321 participants converted to AD. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Amyloid spatial extent with florbetapir-PET for early detection of preclinical Alzheimer’s disease
46/100 ✓ Peer-reviewed Treatments The Journal of Prevention of Alzheimer s Disease
Key finding: EXT showed high cross-sectional reliability and longitudinal stability. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Additional file 1 of Telehealth among Medicare Advantage beneficiaries with and without Alzheimer's Disease and Related Dementias (ADRD), 2018–2024: from pandemic-era surge to post-pandemic decline
32/100 ✓ Peer-reviewed Health systems and care delivery Figshare
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Additional file 1 of Telehealth among Medicare Advantage beneficiaries with and without Alzheimer's Disease and Related Dementias (ADRD), 2018–2024: from pandemic-era surge to post-pandemic decline
41/100 ✓ Peer-reviewed Health systems and care delivery Figshare
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Telehealth among Medicare Advantage beneficiaries with and without Alzheimer's Disease and Related Dementias (ADRD), 2018–2024: from pandemic-era surge to post-pandemic decline
44/100 ✓ Peer-reviewed Health systems and care delivery BMC Health Services Research
Key finding: Among 421,131 MA beneficiaries, telehealth use increased sharply in Q2 2020 for both ADRD and non-ADRD groups, peaking at 33.9 and 30.6% respectively. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Risk Adjustment for Alzheimer Disease and Related Dementias in Medicare Advantage and Health Care Experiences
46/100 ✓ Peer-reviewed Health systems and care delivery JAMA Network Open
Key finding: Among 5353 MA beneficiary observations (1239 [23.1%] aged 65-74 years; 3127 [58.4%] aged ≥75 years; 1785 male [33.3%]), 1629 (30.4%) reported a diagnosis of ADRD, and 3724 (69.6%) did not report an ADRD diagnosis. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-13
Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE)
49/100 ✓ Peer-reviewed Biomarkers Alzheimer's & Dementia: Translational Research & Clinical Interventions
Key finding: Non-elevated plasma p-tau181 results impacted the diagnosis and use of amyloid PET imaging in a memory clinic. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-11
Music therapy in health care practice: promise, pitfalls, and policy implications
35/100 ✓ Peer-reviewed Health systems and care delivery Frontiers in human neuroscience
Key finding: This review concludes with actionable policy recommendations that are imperative to implementing music-based interventions for person-centered, holistic care and ensuring the sustainability of health care systems in the face of aging populations and rising prevalence of chronic illnesses.
Full summary, score breakdown and related studies → Original source
-
2026-03-11
Microglia protein profiles in CSF across Alzheimer’s disease clinical stages
51/100 ✓ Peer-reviewed Inflammation and the immune system Nature Aging
Key finding: Microglia are implicated in the progression of Alzheimer's disease (AD) pathology from its earliest stages, suggesting that cerebrospinal fluid (CSF) microglia profiling across clinical AD stages can aid in treatment development and monitoring. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-11
ALS and Huntington Disease: Unraveling the Connections between TDP-43 and Huntingtin
40/100 ✓ Peer-reviewed Brain tissue and pathology Journal of Neuroscience
Key finding: Though their etiology and pathology are distinct, recent evidence suggests commonalities between TAR DNA-binding protein (TDP-43), which is associated with 97% of ALS cases, and huntingtin (HTT), the causative protein of HD. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-11
Liver–metabolic stress, apolipoprotein E ε4, and cognition and amyloid burden: findings from the dementia platform Korea trial-ready registry
51/100 ✓ Peer-reviewed Cognitive tests and assessment Frontiers in Aging Neuroscience
Key finding: Routine liver–metabolic indices were associated with cognitive performance, while FIB-4 stage showed effect modification by APOE ε4 in relation to both cognition and amyloid PET SUVR. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-11
Health literacy and urban–rural disparities: a cross-sectional study of access, adherence, and quality of life across the neurological spectrum
52/100 ✓ Peer-reviewed Disparities Frontiers in Public Health
Key finding: One-third of adults with neurological conditions in China have low health literacy, with pronounced socioeconomic and geographic disparities. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-11
Anti‐amyloid antibodies in Europe: Where are we now?
33/100 ✓ Peer-reviewed Treatments British Journal of Clinical Pharmacology
Key finding: In the pivotal study in the overall population, the treatment showed a difference of −0.45 points between lecanemab and placebo in the adjusted mean change from baseline on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) at 18 months (the primary endpoint). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-11
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosis
51/100 ✓ Peer-reviewed Tau biomarkers Nature medicine
Key finding: Elevated p-tau levels have also been associated with cerebral deposition of Danish amyloid and prion protein amyloid. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-10
Multi-site MRI analysis of morphometric differences in brain regions in the presence of hearing loss and tinnitus across the adult lifespan
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors bioRxiv
Key finding: The impact of age and hearing loss on the brain has garnered significant attention, as both factors have been implicated in the development of cognitive impairment or dementia. +4 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-03-10
Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab
47/100 ✓ Peer-reviewed Treatments The Lancet regional health. Europe
Key finding: Recent regulatory approvals of lecanemab and donanemab in the EU mark a significant milestone. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2026-03-10
Healthcare Utilization Among Older Adults With Dementia in France: A Comparative Analysis of a Dementia Village and Traditional Nursing Homes
51/100 ✓ Peer-reviewed End-of-life care Value in Health
Key finding: VLAHE residents had fewer hospitalizations and shorter stays (10.5 vs 15.2 days, P = .0004) than comparable NH residents, particularly for acute care. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-10
LDL oxidation and cerebrovascular aging: mechanisms of endothelial dysfunction, inflammation, and vascular cognitive impairment and dementia
43/100 ✓ Peer-reviewed Inflammation and the immune system Redox Biology
Key finding: Epidemiological evidence suggests that aging is associated with modifications in circulating low-density lipoprotein (LDL) and high-density lipoproteins (HDL), particularly oxidation, which further accelerates neurovascular pathology.
Full summary, score breakdown and related studies → Original source
-
2026-03-10
Fructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases
39/100 ✓ Peer-reviewed Brain tissue and pathology Communications Biology
Key finding: Together, these findings reveal a critical link between metabolic dysregulation and genomic instability in TDP-43 pathology-associated motor neuron diseases, and underscore therapeutic potential of F2,6BP.
Full summary, score breakdown and related studies → Original source
-
2026-03-10
Understanding the family caregivers’ needs in late-stage dementia: a qualitative perspective to inform policy action
40/100 ✓ Peer-reviewed Brain tissue and pathology BMC Geriatrics
Key finding: Family caregivers had information, psychosocial, and self-care needs that were deeply intertwined and frequently coexisted at the same time. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-10
TDP-43 pathology triggers neuroinflammation and cognitive impairment by inducing microglial necroptosis
36/100 ✓ Peer-reviewed Brain tissue and pathology EMBO Molecular Medicine
Key finding: In this study, we demonstrated that cytoplasmically mis-localized TDP-43 exacerbated neuroinflammation, induced cell death, and impaired phagocytic function in microglial cells, primarily through receptor interacting serine/threonine kinase 3 (RIPK3)-dependent necroptosis. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-10
Chemical and Molecular Strategies in Restoring Autophagic Flux in TDP-43 Proteinopathy
36/100 ✓ Peer-reviewed Brain tissue and pathology Molecules
Key finding: The cytoplasmic accumulation of TDP-43 aggregates remains a persistent pathological hallmark of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and limbic-predominant age-related TDP-43 encephalopathy (LATE). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2026-03-09
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's disease
52/100 ✓ Peer-reviewed Biomarkers Brain communications
Key finding: This suggests that, despite the above correlations, imaging provides additional information. +1 more finding
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →